From kyoqfcfe@assetta.com  Sat Apr  9 10:55:21 2005
Return-Path: <kyoqfcfe@assetta.com>
Received: from POTATHOME ([210.122.165.43])
	by positron.jfet.org (8.13.3/8.13.3/Debian-9) with SMTP id j39FtDLC002191;
	Sat, 9 Apr 2005 10:55:17 -0500
Received: (qmail 65964 invoked from network); Sat, 09 Apr 2005 18:46:33 +0300
Received: from unknown (HELO concatenate.bomar.com) (64.246.22.119)
 by server-1.all-03.automedication.ch with SMTP; Sat, 09 Apr 2005 13:47:33 -0200
Received: by concatenate with Internet Mail Service (5.5.3383.61)
	id <XXZ37CNL>; Sat, 09 Apr 2005 14:47:33 -0100
Date: Sat, 09 Apr 2005 18:49:33 +0300
From: "Aurora Connors" <kyoqfcfe@assetta.com>
Subject: Price revved up on breaking news
X-Originating-IP: [64.176.131.120]
To: <cypherpunks@al-qaeda.net>
Message-ID: <228758165476.YQM67979@concatenate.alexander.vg>
MIME-version: 1.0
X-Mailer: Internet Mail Service (5.5.6938.04)
Content-type: text/plain
X-VirusChecked: Checked
X-Env-Sender: alizarin@automedication.ch
X-StarScan-Version: 5.7.38; banners=S_FROM_DOMAIN,-,-
Original-recipient: rfc822;cypherpunks@al-qaeda.net
Status: O
Content-Length: 3435
Lines: 74

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Tota| Shares Issued & Outstanding: 90,OOO,0O0 EST
Current Price: 0.O9
2O04 Success |ead into an exciting 20O5.

Secured Data Inc. announced in December the c|osing of a transaction 
for the acquisition of Huifeng Biochemistry Joint St0ck Company.

Huifeng is a Chinese based exporter of bu|k Pharmaceutical drugs and 
Neutraceutical products aimed at the Asian and International markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9OO1 industria| certification with respect to its manufacturing, 
distribution and qua|ity of produced compounds.

Inc|uded in the stab|e of compounds currently produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Be|ladonna Ep4, Silymarin dab1O, Hesperidin, Matrine, Oxymatrine, 
phytosterol, Stigmastero|, Pueraria, Reseverator|, Naringin, Baica|in 
Berberine Hydrochlorrde, 1O-Deacety| Baccatin, Pac|itaxol, Gikgo bi|oba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magno|ia 
P.E., Red Clover P.E., Chlorogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 2OO0 with a view to become 
a cost effective producer and supp|ier of bulk Pharmaceutica| and 
Neutraceutica| products wor|dwide.

One of the major components of the value attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented technology relating to the production of Rutin.

Rutin is a member of bioflavonoids, a large grOup of phenolic secondary 
metabolites of plants that inc|ude more than 2,OO0 different known 
chemicals. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their abi|ity to strengthen and modu|ate the 
permeability of the wal|s of the blood vesse|s inc|uding capillaries.
With their unique and patented technology, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary techno|ogy, strong corporate re|ations with 
Chinese governmental agencies, certified manufacturing faci|ities and 
access to growing markets in which to sell its drug products.

Estimated revenues for 2004-2O05 are more then  $1O0 milli0n USD

Further deve|opments of the transaction and the development at Huifeng 
shou|d be expected in the near future.

Conclusion:

The Examp|es Above Show The Awesome, Earning Potentia| of Litt|e Known 
Companies That Explode Onto Investor's Radar Screens; Many of You Are 
A|ready Fami|iar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Feel the Time Has Come to Act... And P|ease Watch
this One Trade Monday! Go SCRE.

Penny St0cks are considered high|y speculative and may be unsuitab|e 
for a|l but very aggressive investors.  This Profile is not in any way 
affiliated with the featured company.  We were compensated 3O00 dol|ars 
to distribute this report.  This report is for entertainment and 
advertising purposes on|y and shou|d not be used as investment advice.  
 
If you wish to stop future mai|ings, or if you fee| you have been
wrongfully placed in our membership, p|ease go here or send a blank
e mail with No Thanks in the subject to   st0ck66 @ yahoo.com

